Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Breast Cancer × XMT-1522 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1 Breast 1

Conditions

Advanced Breast Cancer 1

Interventions

Fulvestrant 4 palbociclib 3 Letrozole 3 Paclitaxel 2 sonidegib 1 ribociclib 1 irinotecan sucrosofate 1 elacestrant 1 XMT-1522 1 Vorinostat 1 Sirolimus 1 Ritonavir 1 Population Groups 1 Itraconazole 1 Immunotherapy, Adoptive 1 Histone Deacetylase Inhibitors 1 FCN-437c 1 Docetaxel 1 Decitabine 1 Dasatinib 1 Combined Modality Therapy 1 Capecitabine 1 CYH33 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02952729 2021-02-24

Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2

Mersana Therapeutics

Phase 1 Completed

BreastGastrointestinalThoracic

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡